| Authors: |
Packer M; Baylor Heart and Vascular Institute, Dallas, Texas, USA; Imperial College, London, United Kingdom. Electronic address: milton.packer@baylorhealth.edu., Ho J; Harvard Medical School, Boston, Massachusetts, USA; CardioVascular Institute, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Petrie MC; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom., Schiattarella GG; Max Rubner Center for Cardiovascular Metabolic Renal Research, Deutsches Herzzentrum der Charité, Charité-Universitätsmedizin, German Centre for Cardiovascular Research, Partner Site Berlin, Berlin, Germany; Translational Approaches in Heart Failure and Cardiometabolic Disease, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany; Division of Cardiology, Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy., Butler J; Baylor Scott and White Research Institute, Dallas, Texas, USA; University of Mississippi School of Medicine, Jackson, Mississippi, USA., Lam CSP; Cardiovascular and Metabolic Disorders Programme, Duke-National University of Singapore Medical School, Singapore, Singapore; National Heart Centre Singapore, Singapore., Vaduganathan M; Division of Cardiovascular Medicine Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Zannad F; Centres d'Investigation Clinique, INSERM, Centre Hospitalier Régional Universitaire de Nancy, Université de Lorraine, Nancy, France., Borlaug BA; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA. |
